Abstract
Background
The efficacy and safety of bariatric surgery have been poorly studied in patients affected with HIV. Although sleeve gastrectomy (SG) is the most widely used procedure in many countries, most of the published literature reported results with the gastric bypass (GBP) procedure on morbidly obese HIV patients.
Methods
We have evaluated retrospectively, in eight consecutive patients who underwent a SG, its effect in weight loss and its impact on the treatment and on the markers of HIV infection.
Results
Seven out of eight patients were females. The mean age was 46 years, with a median preoperative BMI of 42 kg/m2. The mean duration of HIV infection and CD4 cell count were 13.4 years and 457 cells/mm3, respectively. The mean weight loss was 37 kg in 20 months, the excess BMI loss was 80.8 ± 30.9 %, and the excess weight loss is 81.5 ± 28.9 % with one minor complication. CD4 counts were unchanged. Three patients had therapy modifications that were unrelated to bariatric surgery. Two patients had a therapeutic drug monitoring before and after the intervention. Plasma concentrations remained in therapeutic levels after the SG. Most comorbidities disappeared postoperatively, decreasing the cardiovascular risk.
Conclusions
The sleeve gastrectomy was safe and effective with no consequences on CD4 counts and viral load in HIV-affected obese patients. It should be considered as a part of the treatment in morbidly obese HIV patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
UNAIDS report on the global AIDS epidemic 2013. [cited 29 October 2013]; Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
Keithley JK, Duloy AM, Swanson B, et al. HIV infection and obesity: a review of the evidence. J Assoc Nurses in AIDS Care: JANAC. 2009;20(4):260–74.
Miller M, Kahraman A, Ross B, et al. Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy. Eur J Med Res. 2009;14(9):369–77.
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. JAMA: J Am Med Assoc. 2004;292(14):1724–37.
Selke H, Norris S, Osterholzer D, et al. Bariatric surgery outcomes in HIV-infected subjects: a case series. AIDS Patient Care STDS. 2010;24(9):545–50.
Fried M, Yumuk V, Oppert J-M, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts. 2013;6(5):449–68.
Catheline J-M, Cohen R, Khochtali I, et al. Traitement de la super obésité morbide par gastrectomie longitudinale. Presse Med. 2006;35(3):383–7.
Fazylov R, Soto E, Merola S. Laparoscopic gastric bypass surgery in human immunodeficiency virus-infected patients. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2007;3(6):637.
Flancbaum L, Drake V, Colarusso T, et al. Initial experience with bariatric surgery in asymptomatic human immunodeficiency virus-infected patients. Surg Obes Relat Dis. 2005;1(2):73–6.
Keidar A, Hershkop KJ, Marko L, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetologia. 2013:1-5.
Consten EC, Gagner M, Pomp A, et al. Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane. Obes Surg. 2004;14(10):1360–6.
Cohen R, Uzzan B, Bihan H, et al. Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes Surg. 2005;15(10):1501–2.
Leeman J, Chang YK, Lee EJ, et al. Implementation of antiretroviral therapy adherence interventions: a realist synthesis of evidence. J Adv Nurs. 2010;66(9):1915–30.
Sardo P, Walker JH. Bariatric surgery: impact on medication management. Hosp Pharm. 2008;43(2):113–20.
Brocks DR, Ben-Eltriki M, Gabr RQ, et al. The effects of gastric bypass surgery on drug absorption and pharmacokinetics. Expert Opin Drug Metab Toxicol. 2012;8(12):1505–19.
Michalaki MA, Gkotsina MI, Mamali I, et al. Impaired pharmacokinetics of levothyroxine in severely obese volunteers. Thyroid: Off J Am Thyroid Assoc. 2011;21(5):477–81.
Kamimura M, Watanabe K, Kobayakawa M, et al. Successful absorption of antiretroviral drugs after gastrojejunal bypass surgery following failure of therapy through a jejunal tube. Intern Med. 2009;48(12):1103–4.
Boffito M, Lucchini A, Maiello A, et al. Lopinavir/ritonavir absorption in a gastrectomized patient. AIDS. 2003;17(1):136–7.
Palermo B, Bosch RJ, Bennett K, et al. Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapy. HIV Clin Trials. 2011;12(4):222–7.
Conflict of Interest
All authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fysekidis, M., Cohen, R., Bekheit, M. et al. Sleeve Gastrectomy Is a Safe and Efficient Procedure in HIV Patients with Morbid Obesity: a Case Series with Results in Weight Loss, Comorbidity Evolution, CD4 Count, and Viral Load. OBES SURG 25, 229–233 (2015). https://doi.org/10.1007/s11695-014-1350-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-014-1350-7